Utility of Optical Imaging in a Patient With Recurrent, Multifocal Hydroxyurea-Associated Basal Cell Carcinoma

Dermatol Surg. 2022 Jan 1;48(1):155-156. doi: 10.1097/DSS.0000000000003279.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Basal Cell / chemically induced
  • Carcinoma, Basal Cell / diagnosis*
  • Carcinoma, Basal Cell / surgery
  • Female
  • Head and Neck Neoplasms
  • Humans
  • Hydroxyurea / adverse effects*
  • Middle Aged
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasm, Residual / surgery
  • Optical Imaging*
  • Scalp
  • Skin / diagnostic imaging
  • Skin Neoplasms / chemically induced
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / surgery
  • Thrombocythemia, Essential / drug therapy

Substances

  • Hydroxyurea